Our Take: Pharmacists specializing in oncology pursue the Board Certified Oncology Pharmacist credential, issued by the Board of Pharmacy Specialties, to establish expertise in cancer treatment and medication management. This certification validates advanced knowledge critical in clinical healthcare settings where precision pharmaceutical care directly impacts patient outcomes. The credential carries tangible career value, with 123 active U.S. job postings currently available and professionals commanding an average salary of $177,000 annually. Candidates investing in this credential pay a $575 exam fee for BPS members, with recertification required every seven years to maintain currency in this rapidly evolving field. For pharmacists committed to oncology practice, this specialization represents both professional credibility and competitive compensation in an increasingly specialized healthcare market.